Table 2 Characteristics of complications and their targeted treatment
N = 201 | Treatment of complication | N (%) | ||
Patients with complications, n (%) | 65 (32.3) | |||
Complication | N = 88 | |||
Complication, n (%) | Disseminated tuberculosis Miliary TB Other | 30 (34.1) 18 12 | ||
Acute respiratory failure related to extensive lung disease Pneumonia Miliary TB ARDS | 23 (26.1) 13 7 3 | Supplemental oxygen therapy Non-invasive mechanical ventilation Invasive mechanical ventilation | 23 (100) 3 (13.0) 3 (13.0) | |
Pleural empyema | 6 (6.8) | Chest tube and intrapleural fibrinolytics Medical thoracoscopy Surgical thoracoscopy/VATS | 4 (66.7) 2 (33.3) 2 (33.3) | |
Life-threatening haemoptysis | 5 (5.7) | Bronchial artery embolization Tranexamic acid intravenous administration Blood transfusion Vasopressor medications | 3 (60.0) 5 (100) 1 (20.0) 1 (20.0) | |
SIADH | 4 (4.5) | Water restriction and/or administration of hypertonic solution | 2 (50.0) | |
Pulmonary embolism | 4 (4.5) | Anticoagulation | 3 (75.0) | |
Complicated spondylodiscitis | 3 (3.4) | Neurosurgery | 3 (100) | |
Miscarriage/fetal complications | 3 (3.4) | Abdominal/Gynecological surgery | 2 (66.7) | |
Pneumothorax | 2 (2.3) | Chest tube | 2 (100) | |
Brain stroke | 2 (2.3) | Supportive medical care | 2 (100) | |
Cardiac tamponade | 1 (1.1) | Corticosteroids and supportive medical care | 1 (100) | |
Cerebral oedema | 1 (1.1) | Hyperosmolar agent (mannitol) | 1 (100) | |
Hydronephrosis | 1 (1.1) | Abdominal surgery (nephrectomy) | 1 (100) | |
Gastrointestinal perforation | 1 (1.1) | Abdominal surgery | 1 (100) | |
Intestinal occlusion | 1 (1.1) | Abdominal surgery | 1 (100) | |
Gastrointestinal haemorrhage | 1 (1.1) | Blood transfusion | 1 (100)* | |